Home/Filings/4/0001079973-10-000571
4//SEC Filing

Buckland Andrew J 4

Accession 0001079973-10-000571

CIK 0001006028other

Filed

May 9, 8:00 PM ET

Accepted

May 10, 8:45 AM ET

Size

6.0 KB

Accession

0001079973-10-000571

Insider Transaction Report

Form 4
Period: 2010-05-06
Buckland Andrew J
Chief Financial Officer
Transactions
  • Award

    Stock Option

    2010-05-06+80,00080,000 total
    Exercise: $3.09From: 2011-05-06Exp: 2020-05-06Common Stock (80,000 underlying)
Footnotes (1)
  • [F1]10 year term, vesting in fourths over 4 years. Granted pursuant to PURE Bioscience 2007 Equity Compensation Plan.

Issuer

PURE BIOSCIENCE

CIK 0001006028

Entity typeother

Related Parties

1
  • filerCIK 0001332290

Filing Metadata

Form type
4
Filed
May 9, 8:00 PM ET
Accepted
May 10, 8:45 AM ET
Size
6.0 KB